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ABSTRACT
Objective: To assess, in a sample of systematic
reviews of non-pharmacological interventions, the
completeness of intervention reporting, identify the
most frequently missing elements, and assess review
authors’ use of and beliefs about providing intervention
information.
Design: Analysis of a random sample of systematic
reviews of non-pharmacological stroke interventions;
online survey of review authors.
Data sources and study selection: The Cochrane
Library and PubMed were searched for potentially
eligible systematic reviews and a random sample of
these assessed for eligibility until 60 (30 Cochrane, 30
non-Cochrane) eligible reviews were identified.
Data collection: In each review, the completeness of
the intervention description in each eligible trial
(n=568) was assessed by 2 independent raters using
the Template for Intervention Description and
Replication (TIDieR) checklist. All review authors
(n=46) were invited to complete a survey.
Results: Most reviews were missing intervention
information for the majority of items. The most
incompletely described items were: modifications,
fidelity, materials, procedure and tailoring (missing
from all interventions in 97%, 90%, 88%, 83% and
83% of reviews, respectively). Items that scored better,
but were still incomplete for the majority of reviews,
were: ‘when and how much’ (in 31% of reviews,
adequate for all trials; in 57% of reviews, adequate for
some trials); intervention mode (in 22% of reviews,
adequate for all trials; in 38%, adequate for some
trials); and location (in 19% of reviews, adequate for
all trials). Of the 33 (71%) authors who responded,
58% reported having further intervention information
but not including it, and 70% tried to obtain
information.
Conclusions: Most focus on intervention reporting
has been directed at trials. Poor intervention reporting
in stroke systematic reviews is prevalent, compounded
by poor trial reporting. Without adequate intervention
descriptions, the conduct, usability and interpretation
of reviews are restricted and therefore, require action
by trialists, systematic reviewers, peer reviewers and
editors.
INTRODUCTION
Inadequate descriptions of interventions in
randomised trials, with crucial details missing
from many, have been identiﬁed as a
problem for both implementation of
research and its synthesis. For non-
pharmacological interventions, the problem
is even greater, with more than half of trials
lacking essential information about the inter-
ventions.1 A serious consequence of interven-
tion details missing from trial reports is that
it hampers clinicians from using the inter-
ventions in practice. Yet it is systematic
reviews, rather than trials, that many clini-
cians turn to when looking for evidence. For
effective interventions to make their way into
practice, clinicians need to know the details
Strengths and limitations of this study
▪ Analysis of intervention reporting in 568 trials
from a random sample of 60 systematic reviews
(both Cochrane and non-Cochrane reviews).
▪ Intervention descriptions in each eligible trial, in
each review, were assessed by two independent
raters using the Template for Intervention
Description and Replication (TIDieR) checklist.
▪ A parallel survey of the corresponding author
(n=46) of each included review was also
conducted.
▪ Response rate to the author survey was good
(71%), although there may have been recall bias
and responses from authors who were interested
in the topic.
▪ Our sample contained only reviews of non-
pharmacological and non-surgical stroke inter-
ventions, limiting generalisability of the results.
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of the intervention and be able to answer the question
of ‘How do I actually provide the intervention that this
review is recommending?’
Exploration of the completeness of reporting of inter-
ventions in systematic reviews has received little atten-
tion. Among the recommendations of studies into the
applicability and usability of systematic reviews, it has
been noted that more detailed information about inter-
ventions should be included.2 3 Lack of usefulness has
been identiﬁed as a barrier to the uptake of evidence
from systematic reviews.4 A preliminary analysis of 25 sys-
tematic reviews, sourced from a pool of reviews judged
to be of high quality, found that only 12% of reviews
had sufﬁcient intervention information to be replicable
(as assessed by a single question).5 Detailed analysis of
the reporting of interventions in a sample that includes
both Cochrane and non-Cochrane systematic reviews has
not occurred.
While this issue is problematic for nearly all non-
pharmacological interventions, some of the earliest work
to identify effective components of complex non-
pharmacological interventions and facilitate implemen-
tation of systematic review results was done for stroke.6
Rehabilitation is a major part of stroke care,7 yet
evidence-practice gaps abound. Stroke rehabilitation is
frequently acknowledged as a ‘black box’,8 with limited
knowledge about what are the effective components of
interventions and their features (eg, optimal intensity,
duration and timing).
Uptake of evidence into practice is hampered by these
knowledge gaps and a need for rehabilitation to be stan-
dardised based on the best evidence has been identiﬁed
as one of the priorities of the stroke world agenda.9
However, progress towards evidence-based rehabilitation
will be hindered if trials and reviews do not clearly
describe their interventions. Using a sample of system-
atic reviews of non-pharmacological stroke interventions,
this study aimed to: (1) assess the completeness of
reporting of interventions in systematic reviews; (2) iden-
tify the most frequently missing elements in descriptions
of interventions; and (3) survey review authors about
their use of and beliefs about intervention information
in systematic reviews.
METHODS
Search strategy and selection of reports of trials
To be eligible for inclusion, reviews had to be a system-
atic review of non-pharmacological and non-surgical
interventions which were provided to a stroke popula-
tion. Non-pharmacological interventions were deﬁned as
interventions, including rehabilitation, psychotherapy,
behavioural interventions, non-surgical technical proce-
dures and devices, and complementary medicine.1
Reviews which included trials of both non-
pharmacological and pharmacological interventions
were eligible for inclusion as a review, although only the
non-pharmacological interventions were rated. Reviews
were not eligible if they were reviews of only pharmaco-
logical or surgical interventions, or of diagnostic or
screening tests.
We aimed to randomly select 30 Cochrane and 30
non-Cochrane systematic reviews of non-pharmacological
and non-surgical stroke interventions. Though we did
not do a formal sample size calculation, we were aware
that 60 systematic reviews should have at least 500 studies
(Cochrane reviews have a median of 8 trials;
non-Cochrane, a median of 23).10 Hence, estimates of
proportions would have 95% CIs better than ±7% which
we felt sufﬁcient for the descriptive purposes of this
study. We used a stratiﬁed sampling strategy, so that a
matched number of Cochrane and non-Cochrane
reviews were obtained. Our rationale for this is that
Cochrane reviews are high proﬁle and high impact
reviews, but account for approximately 10% of all pub-
lished reviews,11 and in a random sample of reviews,
these would be under-represented. A medical librarian
experienced in conducting systematic reviews helped
develop and run the searches. We ﬁrst searched the
current (Issue 2, 2013) Cochrane Library for all com-
pleted reviews published by the Cochrane Stroke Group,
which identiﬁed 156 Cochrane reviews on stroke. Two
people (SE, TCH) independently screened titles and
abstracts to identify reviews of non-pharmacological and
non-surgical interventions (n=58). We then developed a
search strategy that included the MeSH terms used to
index the selected Cochrane reviews and searched in
PubMed with the strategy: MeSH descriptor[Stroke]
explode all trees, with qualiﬁers of[Complications—CO,
Psychology—PX, Rehabilitation—RH]; medline[tiab]
OR (systematic[tiab] AND review[tiab]) OR
meta-analysis[pt]; and excluding publications which had
the Cochrane Database of Systematic Reviews as a
source. The search was limited to the most recent 5-year
period (August 2008–2013) and produced 244 results.
The article identiﬁcation numbers from all of the arti-
cles in both the Cochrane and non-Cochrane search
results were separately exported to Excel. A computer-
based random number generator was then used to
select 30 reviews from each set of search results. The full
text of the selected reviews was examined by two raters
(SE, ET) to identify reviews that met the inclusion cri-
teria as described above. This process continued until 30
reviews from each search (total of 60 reviews) were iden-
tiﬁed. Disagreements about unclear eligibility were
resolved by discussion.
Rating of intervention reporting in each systematic review
For each included systematic review, the eligibility of
each intervention in each trial was assessed before the
intervention reporting was assessed. Interventions were
eligible if they were: (1) a non-pharmacological inter-
vention or a complex intervention in which the major
focus was a non-pharmacological component; and (2)
evaluated in a randomised trial.
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The completeness of reporting of each eligible inter-
vention in each systematic review was assessed by two
authors (SE, ET) independently using the Template for
Intervention Description and Replication (TIDieR)
guide and checklist, which was developed to provide
authors and peer reviewers with guidance about the
essential elements of interventions that should be
reported.12 The TIDieR checklist contains 12 items (see
table 1). For this study, item 1 (intervention name or
phrase) was not scored as this is unlikely to be reported
for each intervention in a systematic review. Item 12
(actual/extent of intervention ﬁdelity) was scored as not
applicable if item 11 (planning/assessment of interven-
tion ﬁdelity) was scored as inadequate. When trials con-
tained evaluations of more than one eligible
intervention (such as by using three groups or a factorial
design), the reporting of each intervention was assessed
separately. Items missing from the intervention descrip-
tion, or not described in sufﬁcient detail for replication,
were considered to be incomplete. For interventions
which were assessed as being incompletely reported, we
recorded comments about what was missing. If review
authors reported that intervention details were
described further in other sources (such as websites,
online appendices or reference materials), we located
and examined these additional sources before complet-
ing the rating of the checklist items. The raters com-
pleted the assessment of reviews in blocks of 5 and after
each block assessment, discussed their ratings.
Disagreements in ratings were resolved by discussion
between the two assessors, with a third author (TCH)
arbitrating where necessary.
Survey of corresponding review authors
For each systematic review, the corresponding author
was emailed and invited to complete an online survey
via SurveyMonkey. The survey contained eight questions
(a mixture of open-ended, and ﬁxed-choice questions
with the option of providing additional comments) and
asked authors: whether they had additional intervention
information that was not reported in the review and the
reason for this; whether they attempted to obtain add-
itional intervention information and if so, methods used
to obtain such information; details of additional infor-
mation obtained; and the role of intervention descrip-
tions in systematic reviews. If no response was received, a
reminder email was sent after 2 weeks, and after a
further 4 weeks.
Data analysis
Details of ratings and authors’ survey responses were
entered into Excel and used to analyse data descriptively.
For each systematic review, we synthesised the ratings
across the multiple interventions for each TIDieR item
as: adequate for all (indicating that the item had been
clearly reported for all of the eligible interventions in
Table 1 Brief description of the Template for Intervention Description and Replication (TIDieR) items that were used to
assess intervention reporting
Item number* Item name Item description
2 Why Describe any rationale, theory or goal of the elements essential to the intervention
3 What: materials Describe any physical or informational materials used in the intervention, including those
provided to participants or used in intervention delivery or in training of intervention
providers; provide information on where the materials can be accessed (eg, online
appendix, URL)
4 What: procedures Describe each of the procedures, activities, and/or processes used in the intervention,
including any enabling or support activities
5 Who provided For each category of intervention provider (eg, psychologist, nursing assistant), describe
their expertise, background and any specific training given
6 How Describe the modes of delivery (eg, face-to-face or by some other mechanism, such as
internet or telephone) of the intervention and whether it was provided individually or in a
group
7 Where Describe the type(s) of location(s) where the intervention occurred, including any
necessary infrastructure or relevant features
8 When and how
much
Describe the number of times the intervention was delivered and over what period of
time, including the number of sessions, their schedule, and their duration, intensity or
dose
9 Tailoring If the intervention was planned to be personalised, titrated or adapted, then describe
what, why, when and how
10 Modifications If the intervention was modified during the course of the study, describe the changes
(what, why, when and how)
11 How well: planned If intervention adherence or fidelity was assessed, describe how and by whom, and if
any strategies were used to maintain or improve fidelity, describe them
12* How well: actual If intervention adherence or fidelity was assessed, describe the extent to which the
intervention was delivered as planned
*Item 1 was not scored for this study; item 12 was scored as ‘not applicable’ if item 11 was scored as inadequate.
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the review); adequate for some (indicating that the item
had been described clearly for some, but not all, of the
eligible interventions in the review); or adequate for
none (indicating that the item had been not described
clearly or not at all for any of the interventions in the
review). The broad interventions covered by the eligible
reviews (as shown in table 2) were categorised by the
two raters (ET, SE) according to the National Stroke
Foundation’s Stroke Guidelines categories.13 When com-
paring Cochrane and non-Cochrane reviews, we col-
lapsed the ‘adequate for all’ and ‘adequate for some’
into one category. Authors’ responses to open-ended
survey responses were independently coded into the-
matic clusters by two authors (TCH, SE), with any dis-
crepancies discussed until consensus was reached.
RESULTS
Our sample of 60 systematic reviews included a total of
568 eligible trials and 589 eligible interventions (mean
of 10.1 eligible interventions per Cochrane review, range
0–51; mean of 9.5 eligible interventions per
non-Cochrane review, range 6–28). Table 2 shows the
broad interventions covered by the reviews, along with
the number of eligible interventions. Two Cochrane
reviews identiﬁed no studies eligible for inclusion and
were not able to be analysed further for this study.
Completeness of intervention descriptions in systematic
reviews
Most reviews were missing information for the majority of
items (ﬁgure 1). The most incompletely described items
were: modiﬁcations, intervention ﬁdelity, materials, pro-
cedure and tailoring (missing from all interventions in
97%, 90%, 88%, 83% and 83% of reviews, respectively).
Items that scored higher, but still incomplete for the
majority of reviews, were: details of ‘when and how much’
of the intervention (in 31% of reviews, it was adequate for
all interventions; in 57% of reviews, it was adequate for
some interventions); how (ie, the mode) the intervention
was provided (in 22% of reviews, it was adequately
reported for all interventions; in 38% of reviews, it was
adequately reported for some interventions); and where
(setting) the intervention was provided (in 19% of reviews,
it was adequate for all interventions; and adequate for
some interventions in 19% of reviews). Only two reviews,
both non-Cochrane reviews, directed readers to other
sources for additional intervention information. In both of
these reviews, supplemental tables contained additional
data, and as part of this, also contained information about
item 8 (‘when and how much’ of the intervention).
The completeness of intervention reporting of
Cochrane reviews compared with non-Cochrane reviews
is shown in ﬁgure 2, where, for each TIDieR item, the
mean percentage of systematic reviews in which there
were adequate description of all or some of the interven-
tions in the review is presented. Reporting of details of
interventions was clearly better (in ≥20% of reviews) in
Cochrane reviews for 5 of the 11 items: intervention
rationale; procedure; intervention provider; how the
intervention was delivered; and where the intervention
was delivered. For item 11 (assessment of intervention
ﬁdelity or adherence), there was a slightly higher per-
centage of non-Cochrane reviews (13%), compared with
Cochrane reviews (7%), in which some or all of the
interventions in the reviews described this item,
although this item was only reported in a very small pro-
portion of reviews. For the remaining ﬁve items (materi-
als; when and how much; tailoring; modiﬁcations;
actual/extent of ﬁdelity), there was little difference
between the completeness of reporting in Cochrane
reviews compared with non-Cochrane reviews.
Survey of review corresponding authors
We contacted the 46 corresponding authors of the 58
reviews with eligible interventions (several authors were
corresponding authors for two or more reviews). Of the
33 (71%) authors who responded, 19 (58%) reported
that they had further information about the intervention
that was not included in the review, while 23 (70%) indi-
cated that they had tried to obtain further information
about the intervention as part of the review, using
various methods, with variable success. Reasons for not
attempting to obtain further intervention information
included: not perceived as necessary as part of a review,
not needed because interventions were already fully
described, or would not subsequently have been able to
incorporate the information into the review.
A summary of responses to questions where authors
could provide comments and elaborate on these issues is
shown in table 3. Some authors acknowledged the
importance of completely describing interventions in
reviews, with multiple reasons given, such as helping
with decisions about study inclusion, appropriateness of
data synthesis and subgroup analysis, and facilitating the
use of interventions in practice. Some authors commen-
ted that reviews typically do not provide sufﬁcient inter-
vention information, while others commented that such
information could be useful as part of the review
process, but did not need to be included in the review
itself. Suggested contributors to the problem were lack
of details provided in the original trials and word limits
(for both trials and reviews).
DISCUSSION
We found a high rate of incomplete reporting of inter-
vention items in systematic reviews, with details describ-
ing most intervention elements missing from the
majority of the reviews. This has important conse-
quences for the conduct, interpretation and use of the
reviews. As trials are synthesised into reviews, the
problem of intervention details missing from trial publi-
cations is compounded. Lack of intervention detail
affects more than the usability and interpretation of a
completed review. It can also hamper steps in the review
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Table 2 Categories of interventions of the included systematic reviews, the number of eligible studies and interventions, and
excluded studies
Intervention category
Systematic reviews
Number of eligible studies
(interventions) included
Number of excluded
studies (main reason)
Cochrane
reviews (n)
Non-Cochrane
reviews (n)
Cochrane
reviews
Non-Cochrane
reviews
Organisation of service
Care after hospital
discharge
5 1 26 (26) 15 (12)
Hospital care 2 1 50 (50) 4 (4) 5 (not RCTs)
Patient and carer/family
support
1 0 16 (18) 0 (0)
Rehabilitation
Upper limb 2 11 24 (24) 106 (114) 10 (not stroke
population);
17 (not RCTs)
Physical activity 2 5 13 (13) 50 (51) 13 (not RCTs)
Amount, intensity and
timing
1 0 1 (1) 0 (0)
Cognition 5 2 23 (23) 7 (9) 7 (not RCTs)
Communication 1 0 39 (51) 0 (0)
Sensorimotor
impairment
2 4 13 (13) 51 (48) 7 (not stroke population)
Activities of daily living 2 0 18 (21) 0 (0)
Complications
Mood disturbance 1 1 2 (2) 6 (5) 4 (pharmacological)
Loss of cardiorespiratory
fitness
1 2 32 (32) 17 (15) 1 (not RCT)
Subluxation 2 0 18 (19) 0 (0)
Poor hygiene 1 0 3 (3) 0 (0)
Fatigue 1 0 1 (1) 0 (0) 2 (pharmacological)
Complementary and
alternative therapy for
acute management
1 1 7 (7) 8 (8)
Lifestyle modification for
secondary prevention
0 2 0 (0) 18 (19) 3 (pharmacological); 17
(protocols)
Total Cochrane reviews 286 studies (304 interventions)
Non-Cochrane reviews 282 studies (285 interventions)
RCT, randomised controlled trial.
Figure 1 Percentage of systematic reviews, per checklist item, in which intervention descriptions were ‘adequate for all
interventions’, ‘adequate for some’ and ‘adequate for none’ of the interventions included in each review.
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process, such as decisions about eligibility, meta-analysis
and subgroup analysis. Some review authors were con-
scious of the problem and attempted to obtain add-
itional information, with variable success.
Strengths of this study include: the use of a compre-
hensive checklist and two independent raters to assess
intervention reporting; the number and variety of
reviews included studies and interventions; inclusion of
both Cochrane and non-Cochrane reviews; and a good
response rate to our author survey. Some of the limita-
tions of the study are that our sample of reviews only
contains non-pharmacological and non-surgical inter-
ventions, and only stroke interventions and hence, the
Cochrane reviews are from only one Cochrane review
group. The extent to which our random sample reﬂects
systematic reviews in stroke and the generalisability of
these results to other conditions and interventions is
unknown. Although the response rate to our author
survey was good (71%), authors with an interest in the
issue may have been more likely to respond, whereas
authors of older reviews may not have responded or
been able to recall information about the questions
asked, and a small number of the authors had authored
more than one of the included reviews. We did not for-
mally measure a single level of agreement between the
raters primarily because an iterative process was used
with the raters comparing ratings after every ﬁve reviews.
There were no items which raters consistently disagreed
on or were notably more problematic than others.
Analysis of the reporting of the intervention elements
in systematic reviews has rarely been studied. Assessment
of the intervention reporting in 25 Cochrane reviews of
acupuncture found that many reviews lacked interven-
tion details, even though the details were often reported
in the trials included in the reviews,14 reinforcing that
lack of details in trials is only one contributor to the
problem. In this study, intervention elements that were
mostly absent from nearly all reviews include details of
intervention procedures, materials, tailoring, modiﬁca-
tions and ﬁdelity. These are the elements that may be
perceived as the most difﬁcult to describe and require
the most words. Yet, for intervention replication, they
are among the most crucial. Items 3 (materials) and 4
(procedures) have been described as analogous to the
ingredients and methods of a recipe12—without these
details, the intervention cannot be provided with ﬁdelity.
These elements have also been reported as the elements
most frequently missing from publications of rando-
mised trials of non-pharmacological interventions;1 thus,
it is not surprising that these are also among the most
frequently missing elements in reviews. A particular chal-
lenge with these elements is the amount of detail
required to report them adequately. Elements that are
easier and more succinct to report, such as the ‘when
and how much’ of the intervention and its mode of
delivery, were better reported. In Cochrane reviews,
these and other intervention details were typically found
in the Characteristics of Included Studies tables, rather
than in the main text of the review.
For almost half of the TIDieR items, Cochrane reviews
more completely reported intervention details than
non-Cochrane reviews and for all but one of the remain-
ing items, there was no difference between the two
samples of reviews. Better quality reporting of Cochrane
Figure 2 Mean percentage of systematic reviews, per Template for Intervention Description and Replication (TIDieR) checklist
item, in which interventions were described ‘adequately for all’ or ‘adequately for some’ of the interventions in the review, for
Cochrane and non-Cochrane reviews.
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Table 3 Survey questions to and responses from corresponding authors (n=33)
Q. Briefly describe why you did not include this information in the review. Category of response (number of authors providing a response in each category)
and illustrative quotes
Was not relevant (2)
“Didn’t think it was relevant”
Page/word limits (3)
▸ “No detailed description of the interventions because of word limit and because of clarity. Was out of the focus of the review.”
Not included/reported in the review, but used in the review process (6)
▸ “Some of this information was incorporated…when the meta-analyses were being conducted. Without including this information, the study might not have met inclusion
and therefore, would have been excluded.”
▸ “Some data contributed to meta-analysis of outcome data”
▸ “Only used to determine eligibility for inclusion in review”
▸ “Intervention details were not used much in the review but were mostly used to make decisions about inclusion, or sub group allocation”
Other (2)
▸ “Was raised…as points of difference in the discussion.”
▸ “Other reviews covered the interventions…but not with a stroke- specific population.”
Q. If you tried to obtain further information about the intervention/s, how and where from? (n=23) (could choose ≥1 response)
Method of obtaining further information n (%)
Email/fax 21 (91)
Searching for other publications related to original trial/s 16 (70)
Searching for published protocol of original trial/s 13 (57)
Searching clinical trial registries 9 (39)
Face-to-face (eg, semistructured interviews with trialists at conferences) 4 (13)
Telephone 2 (9)
Other (broad intervention approach described in a book, but not specifically about the trial) 1 (4)
Q. If you contacted authors of the trial/s for further intervention information, did the trial author/s respond? (n=22) (could choose ≥1 response)
Response n (%)
All authors who were contacted responded, and provided further information 2 (9)
Some authors who were contacted responded, and provided further information 10 (46)
Some authors responded, but did/could not provide further information (eg, data were so old they were no longer available) 8 (36)
None of the authors who were contacted provided further information 1 (5)
None of the authors responded 3 (14)
Q. If trial authors provided you with additional intervention information, please briefly describe the nature/format of this information. Category of response
(number of authors providing a response) and illustrative quotes Details about intervention components (9)
▸ “Explained what was meant by intervention terms or described tools used for intervention or amount, etc”
▸ “Greater detail about components of the intervention, such as intensity, duration, application details, instructions, etc”
Intervention protocols and intervention materials (3)
▸ “Intervention protocols, greater details about intervention type, implementation, intensity, staff training outlines, descriptions…”
▸ “Authors sent information/material resources used in the intervention, provided a website with more information, provided greater detail about a component of the
intervention, such as intensity or duration”
▸ “Internal reports, draft papers, local protocols”
Q. If you did not attempt to obtain further information about the intervention/s, was there a reason? (provide main reason only) (n=18)
Response from author n (%)
Not needed as interventions were fully described in the original trial 8 (44)
Continued
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reviews than non-Cochrane reviews has been previously
identiﬁed in a cross-sectional sample of reviews10 and a
sample of stroke rehabilitation systematic reviews,15
although these studies did not examine intervention
reporting. Among the reasons suggested for better
reporting in Cochrane reviews are the absence of word
limits, and detailed guidance and policies on review
conduct and reporting.10 A number of the authors sur-
veyed mentioned word limits as a barrier to reporting
intervention details, although presumably these were
authors of non-Cochrane reviews. For reviews where
word limits may prevent detailed reporting, authors are
encouraged to provide intervention details in online
supplementary materials, which is now an option in the
majority of journals.16
However, having no word limit on reviews is clearly
not sufﬁcient to ensure complete reporting of interven-
tion details. As lack of awareness among authors of trials
about what constitutes an adequate description of an
intervention contributes to poor reporting of trials,17 it
may also be problematic for review authors as guidance
for review authors about how to report interventions is
lacking. The most relevant section (7.3.4) of the current
version (V.5.1.0) of the Cochrane Handbook (hand-
book.cochrane.org) does mention that reviews should
provide information that is ‘sufﬁcient for replication’,
and gives a few examples of what this might include (eg,
route of delivery, dose, format, timing). However, this
guidance does not appear in the most recent version
(V.2.3) of Cochrane’s ‘Methodological standards for the
conduct of Cochrane Intervention Reviews’, the most
relevant mandatory standard (C44) simply advises that
“basic characteristics of each study will need to be pre-
sented…, including details of participants, interventions
and comparators…”.18 Other standards that are relevant
but unlikely to be sufﬁcient guidance to facilitate
adequate intervention reporting include: a non-
mandatory standard (C49) that encourages review
authors to contact study authors for details of unpub-
lished information, including ‘details of interventions’;
and a mandatory standard (C7) that requires any restric-
tions (ie, those that are ineligible) on interventions and
comparators to be predeﬁned and explained. While
these standards continue to undergo reﬁnement, the
2012 version (V.1.1) of these standards provided more
details about how interventions should be reported and
encouraged authors to report ‘in a way that allows the
intervention to be replicated’,19 whereas this has been
removed in the 2013 version.18
For non-Cochrane reviews, authors may use the
PRISMA (Preferred Reporting Items for Systematic
Reviews and Meta-analyses) statement as reporting guid-
ance;20 yet it also does not provide guidance about how
to report interventions and only requests ‘study
characteristics’. Review authors may ﬁnd the newly devel-
oped statement that guides intervention reporting for
any evaluative study design (TIDieR) useful when con-
sidering what intervention elements they need details
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about while conducting, and particularly when writing,
the review. Another tool which may help during the
review process is the Oxford Implementation Index21
which aims to assist reviewers to extract and compare
implementation data (includes intervention design)
across trials.
Poor reporting of intervention details in systematic
reviews is part of the broader problem of how to imple-
ment the results of systematic reviews. A recent paper22
described three possible approaches to selecting and
implementing a speciﬁc intervention from a systematic
review. Two of these approaches are dependent on sufﬁ-
cient intervention details being able to be obtained and
the other, the simplest approach (single-trial-based
choice), requires at least some interventions in the
review to be replicable and for agreement about what
constitutes the ‘best’ intervention. One way that review
authors can help review users to consider which inter-
ventions might be most appropriate for their circum-
stance involves providing an ‘intervention options
table’.22 This table could summarise the pros and cons
of the usable and feasible interventions in the review
(and the criteria used to decide this), including ele-
ments of each version of the intervention studied and
differences between trials’ interventions.
In many reviews, authors commented (typically in
the Discussion) that lack of intervention detail made
synthesising, interpreting and using the results difﬁcult
or that trialists should clearly deﬁne each intervention
tested. Reﬂecting this, some authors surveyed reported
contacting trial authors for additional intervention
information—some with success. Those that were able
to obtain additional details described using the infor-
mation in various parts of the review process, such as
deciding on study eligibility and the appropriateness
and interpretation of subgroup and meta-analyses.
While some review authors viewed intervention details
as important in both the conduct and reporting of the
review, others did not include detailed intervention
information in the review report or think it was neces-
sary. Although many systematic review users are aware
of the need to critically appraise them before deciding
whether to use them, appraisal tools typically do not
consider the adequacy of intervention reporting and
how that may have inﬂuenced the review’s steps and
results. Future research that explores whether the com-
pleteness of intervention reporting (of both the experi-
mental and comparison interventions) is related to
variables, such as the quality of the review, would be
valuable.
Most of the focus of poor intervention reporting as a
barrier to evidence interpretation and uptake has been
directed at the primary trials. This study highlights an
even greater problem in systematic reviews, where the
poor reporting of interventions in trials is compounded.
This reinforces the importance of trialists providing sufﬁ-
cient intervention details. This issue is not unique to
intervention details; a recent analysis of selective
reporting bias of harms outcomes identiﬁed that harms
data are incompletely reported in many primary studies
and also in subsequent systematic reviews.23 Both trialists
and systematic review authors have an important role to
play in ensuring that interventions are adequately
reported in systematic reviews. Poor reporting in the
trials, however, is not the sole contributor to the inad-
equacies of intervention reporting in systematic reviews.
As neither the current PRISMA statement or the
Cochrane methodological standards provide guidance
about intervention reporting, authors of reviews should
consider also using guidance about intervention report-
ing and/or a structured method of reporting intervention
details, and peer reviewers and editors should be cogni-
sant of the adequacy with which interventions are
reported in reviews. Having systematic reviews which
contain adequate intervention information will assist at
multiple stages of the review process as well as the inter-
pretation of review results. Ultimately, this will help clini-
cians to implement effective interventions into practice.
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